UF News

Oragenics Develops Automated Intranasal Device for Treating Concussed Patients

Oragenics, Inc., a UF Innovate | Accelerate alumnus company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced it has completed a prototype of its automated intranasal device for use in concussed patients who are initially confused, dazed or unconscious in the acute phase of injury.

Solid Biosciences Joins the Russell 3000® Index

Solid Biosciences Inc., a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases that acquired UF startup AavantiBio, announced it has been added to the broad-market Russell 3000® Index as part of the annual reconstitution, effective July 1st, 2024.

MBI Researchers to Test Novel Treatments for Medulloblastoma

University of Florida researchers have received approval from the Food and Drug Administration to test two new experimental therapies in first-ever human clinical trials for a subtype of medulloblastoma, the most common pediatric malignant brain tumor.

Tech Tuesday: Fire Neural Network

In this week’s Tech Tuesday, UF Innovate host Bethany Gaffey speaks with the CEO of Fire Neural Network about how artificial intelligence is helping to prevent the spread of wildfire.

Want our news in your inbox every Monday morning? You can!

Subscribe Here